Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
ACS Pharmacology & Translational Science|March 6, 2025
Comparative Evaluation and Profiling of Chemical Tools for the Nuclear Hormone Receptor Family 2Max Lewandowski, Romy Busch, Julian A Marschner, et al.ACS Medicinal Chemistry Letters|January 8, 2026
Dual Nurr1/RXR agonism of valerenic acid and synthetic mimetics enables dimer-selective Nurr1 modulationKatharina Scholz, Úrsula López-García, Romy Busch, et al.Journal of Medicinal Chemistry|January 26, 2026
Structural Tuning of Vidofludimus for High-Efficacy NR4A AgonismJan Vietor, Romy Busch, Úrsula López-García, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2022
Nurr1 Modulation Mediates Neuroprotective Effects of StatinsSabine Willems, Julian A Marschner, Whitney Kilu, et al.Journal of Medicinal Chemistry|February 7, 2025
A Nurr1 Agonist Derived from the Natural Ligand DHI Induces Neuroprotective Gene ExpressionMarkus Egner, Romy Busch, Úrsula López-García, et al.Journal of Medicinal Chemistry|July 17, 2025
Carboxylic Acid Bioisosteres Boost Nurr1 Agonist SelectivityTanja Stiller, Christian Gege, Wael Saeb, et al.Journal of Medicinal Chemistry|May 1, 2023
Development of a Potent Nurr1 Agonist Tool for In Vivo ApplicationsJan Vietor, Christian Gege, Tanja Stiller, et al.Journal of Medicinal Chemistry|June 3, 2026
An Activator of Tailless' Repressor Function Stimulates Anti-Neurodegenerative Gene ExpressionEmily C Hank, Romy Busch, Úrsula López-García, et al.Nature Communications|June 18, 2024
Chemogenomics for NR1 nuclear hormone receptorsLaura Isigkeit, Espen Schallmayer, Romy Busch, et al.ACS Medicinal Chemistry Letters|April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 AgonistsAlisa Lang, Niklas Ildefeld, Felix F Lillich, et al.Pageof 2